Mina Desai1, Juanita K Jellyman2, Guang Han2, Marie Beall3, Robert H Lane4, Michael G Ross5. 1. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Department of Obstetrics and Gynecology, Perinatal Research Laboratories, Torrance, CA; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA. Electronic address: mdesai@obgyn.humc.edu. 2. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Department of Obstetrics and Gynecology, Perinatal Research Laboratories, Torrance, CA. 3. Los Angeles Perinatal Association, Los Angeles, CA. 4. Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI. 5. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Department of Obstetrics and Gynecology, Perinatal Research Laboratories, Torrance, CA; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA.
Abstract
OBJECTIVE: We determined the potential programming effects of maternal obesity and high-fat (HF) diet during pregnancy and/or lactation on offspring metabolic syndrome. STUDY DESIGN: A rat model of maternal obesity was created using an HF diet prior to and throughout pregnancy and lactation. At birth, pups were cross-fostered, thereby generating 4 paradigms of maternal diets during pregnancy/lactation: (1) control (Con) diet during pregnancy and lactation (Con/Con), (2) HF during pregnancy and lactation (HF/HF), (3) HF during pregnancy alone (HF/Con), and (4) HF during lactation alone (Con/HF). RESULTS: Maternal phenotype during pregnancy and the end of lactation evidenced markedly elevated body fat and plasma corticosterone levels in HF dams. In the offspring, the maternal HF diet during pregnancy alone programmed increased offspring adiposity, although with normal body weight, whereas the maternal HF diet during lactation increased both body weight and adiposity. Metabolic disturbances, particularly that of hyperglycemia, were apparent in all groups exposed to the maternal HF diet (during pregnancy and/or lactation), although differences were apparent in the manifestation of insulin resistant vs insulin-deficient phenotypes. Elevated systolic blood pressure was manifest in all groups, implying that exposure to an obese/HF environment is disadvantageous for offspring health, regardless of pregnancy or lactation periods. Nonetheless, the underlying mechanism may differ because offspring that experienced in utero HF exposure had increased corticosterone levels. CONCLUSION: Maternal obesity/HF diet has a marked impact on offspring body composition and the risk of metabolic syndrome was dependent on the period of exposure during pregnancy and/or lactation.
OBJECTIVE: We determined the potential programming effects of maternal obesity and high-fat (HF) diet during pregnancy and/or lactation on offspring metabolic syndrome. STUDY DESIGN: A rat model of maternal obesity was created using an HF diet prior to and throughout pregnancy and lactation. At birth, pups were cross-fostered, thereby generating 4 paradigms of maternal diets during pregnancy/lactation: (1) control (Con) diet during pregnancy and lactation (Con/Con), (2) HF during pregnancy and lactation (HF/HF), (3) HF during pregnancy alone (HF/Con), and (4) HF during lactation alone (Con/HF). RESULTS: Maternal phenotype during pregnancy and the end of lactation evidenced markedly elevated body fat and plasma corticosterone levels in HF dams. In the offspring, the maternal HF diet during pregnancy alone programmed increased offspring adiposity, although with normal body weight, whereas the maternal HF diet during lactation increased both body weight and adiposity. Metabolic disturbances, particularly that of hyperglycemia, were apparent in all groups exposed to the maternal HF diet (during pregnancy and/or lactation), although differences were apparent in the manifestation of insulin resistant vs insulin-deficient phenotypes. Elevated systolic blood pressure was manifest in all groups, implying that exposure to an obese/HF environment is disadvantageous for offspring health, regardless of pregnancy or lactation periods. Nonetheless, the underlying mechanism may differ because offspring that experienced in utero HF exposure had increased corticosterone levels. CONCLUSION:Maternal obesity/HF diet has a marked impact on offspring body composition and the risk of metabolic syndrome was dependent on the period of exposure during pregnancy and/or lactation.
Authors: J S Rodriguez; G L Rodríguez-González; L A Reyes-Castro; C Ibáñez; A Ramírez; R Chavira; F Larrea; P W Nathanielsz; E Zambrano Journal: Int J Dev Neurosci Date: 2012-01-05 Impact factor: 2.457
Authors: Kimberly K Vesco; Njeri Karanja; Janet C King; Matthew W Gillman; Nancy Perrin; Cindy McEvoy; Cara Eckhardt; K Sabina Smith; Victor J Stevens Journal: Contemp Clin Trials Date: 2012-03-20 Impact factor: 2.226
Authors: Margaret J R Heerwagen; Melissa R Miller; Linda A Barbour; Jacob E Friedman Journal: Am J Physiol Regul Integr Comp Physiol Date: 2010-07-14 Impact factor: 3.619
Authors: M Romaní-Pérez; A L Lépinay; L Alonso; M Rincel; L Xia; H Fanet; S Caillé; M Cador; S Layé; S Vancassel; M Darnaudéry Journal: Int J Obes (Lond) Date: 2016-12-27 Impact factor: 5.095
Authors: Kimberly P Newton; Haruna S Feldman; Christina D Chambers; Laura Wilson; Cynthia Behling; Jeanne M Clark; Jean P Molleston; Naga Chalasani; Arun J Sanyal; Mark H Fishbein; Joel E Lavine; Jeffrey B Schwimmer Journal: J Pediatr Date: 2017-03-30 Impact factor: 4.406